Opdualag is made up of the immunotherapy drugs nivolumab and relatlimab. You pronounce nivolumab as ni-vol-you-mab. And relatlimab as reh-lat-lih-mab. Nivolumab and relatlimab are types of ...

Metastatic bowel cancer is cancer that has spread from the back passage (rectum) and large intestines (colon) to other parts of the body, such as the liver. Sometimes cancer has spread when it is ...

Early detection and diagnosis (ED&D) research seeks to detect and diagnose consequential precancerous changes and cancer at the earliest possible point at which an intervention might be made, reducing ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. After treatment you see your doctor regularly to make sure the cancer isn’t coming back. If ...

Louth Rotary is a group of professional men and women of all ages who meet regularly to help improve the lives of others in their community and across the world. We love to get involved in fun and ...

This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again. Read more about A trial looking at a drug ...

Not everyone with eye cancer will have changes in sexual desire or how they feel about themselves sexually. You might not notice any changes at all. But you might find cancer changes your body image ...

Cancer (excluding benign, uncertain and unknown behaviour brain, other CNS and intracranial tumours) is the second most common cause of death for males and females aged 15-24. Cancer accounted for 10% ...

Cancer (excluding benign, uncertain and unknown behaviour brain, other CNS and intracranial tumours) is the second most common cause of death for males and females aged 15-24. Cancer accounted for 10% ...

How do atezolizumab and bevacizumab work? Atezolizumab is a type of immunotherapy called a monoclonal antibody. It works by binding to PD-L1 proteins on the surface of cancer cells. This stops cancer ...

Being aware of the groups that are less likely to attend screening will support you to target and tailor interventions. The following groups of people may be less likely to take up breast screening: 1 ...